secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUNIC, INC. (IMUX)
CIK:        0001280776
Form:       8-K
Filed at:   2025-07-11T23:59:59+00:00
Accession:  0001193805-25-001008
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Immunic grants 35M stock appreciation rights to employees and executives at $0.77 strike
--------------------------------------------------------------------------------

- Company authorized up to 35M SARs for employees and exec officers; 22,015,000 to exec officers.
- Exercise price of $0.77 (July 7 closing); settlement in shares subject to shareholder approval to increase plan shares.
- 5M SARs exercisable Aug 1, 2026; 30M contingent on warrant exercises and private placement tranches from Jan 2024 offering.
- Company intends to seek stockholder approval to amend 2019 Omnibus Equity Incentive Plan to increase authorized shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1280776/000119380525001008/0001193805-25-001008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1280776/000119380525001008/e664690_8k-immunic.htm
  HTML page:      https://secwatch.observer/filing/0001193805-25-001008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer